- 专利标题： SUBSTITUTED PIPERIDINE COMPOUND AND USE THEREOF
-
申请号： US15421702申请日： 2017-02-01
-
公开(公告)号： US20170226137A1公开(公告)日： 2017-08-10
- 发明人: Tatsuhiko Fujimoto , Kentaro Rikimaru , Koichiro Fukuda , Hiromichi Sugimoto , Takahiro Matsumoto , Norihito Tokunaga , Mariko Hirozane
- 申请人： Takeda Pharmaceutical Company Limited
- 申请人地址： JP Osaka
- 专利权人： Takeda Pharmaceutical Company Limited
- 当前专利权人： Takeda Pharmaceutical Company Limited
- 当前专利权人地址： JP Osaka
- 优先权： JP2016-019834 20160204
- 主分类号： C07F7/18
- IPC分类号： C07F7/18 ; C07D211/24 ; C07D401/14 ; C07D405/06 ; C07D413/06 ; C07D405/14 ; C07D401/06 ; C07D409/12 ; C07D401/12 ; C07D405/12 ; C07D417/06 ; C07D417/14 ; C07D211/56 ; C07D409/06
摘要：
Provided is a substituted piperidine compound having an orexin type 2 receptor agonist activity. A compound represented by the formula (I): wherein each symbol is as described in the DESCRIPTION, or a salt thereof has an orexin type 2 receptor agonist activity, and is useful as a prophylactic or therapeutic agent for narcolepsy.
公开/授权文献
- US10287305B2 Substituted piperidine compound and use thereof 公开/授权日：2019-05-14